Top Buy
| Security | Buy ▲ | Sell | Buy (1M) | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Krystal Biotech | 18 | 0 | 2 | 0 | €146.35 | €179.60 | 22.716% |
| Exelixis Inc. | 18 | 0 | 3 | 0 | €18.72 | €26.01 | 38.960% |
| Natural Alternat. | 19 | 1 | 2 | 0 | €5.95 | - | - |
| United Therapeutics | 19 | 0 | 4 | 0 | €247.90 | €287.40 | 15.934% |
| G1 Therapeutics | 20 | 1 | 7 | 0 | €3.08 | €10.05 | 226.005% |
| Sutro Biopharma Inc | 21 | 0 | 3 | 0 | €3.82 | €11.04 | 189.068% |
| Iovance Biotherapeutics Inc. | 21 | 3 | 2 | 0 | €8.33 | €25.20 | 202.700% |
| TG Therapeutics Inc. | 22 | 4 | 2 | 0 | €15.15 | €28.06 | 85.220% |
| AbbVie Inc. | 22 | 0 | 2 | 0 | €141.72 | €175.11 | 23.561% |
| Zoetis Inc. A | 23 | 1 | 3 | 0 | €158.20 | €200.06 | 26.459% |
| Intra-Cellular Therapies Inc. | 25 | 0 | 2 | 0 | €62.00 | €79.55 | 28.313% |
| Amgen Inc. | 25 | 0 | 4 | 0 | €274.00 | €296.16 | 8.086% |
| Insmed Inc. | 27 | 2 | 14 | 2 | €46.80 | €50.69 | 8.319% |
| Pfizer Inc. | 27 | 4 | 1 | 0 | €25.77 | €40.66 | 57.778% |
| Merck & Co. Inc. | 28 | 1 | 0 | 0 | €116.80 | €124.92 | 6.954% |
| Neurocrine Bioscience | 31 | 0 | 8 | 0 | €124.65 | €140.60 | 12.799% |
| Cytokinetics Inc. | 31 | 2 | 9 | 1 | €44.40 | €83.06 | 87.067% |
| Regeneron Pharmaceuticals Inc. | 36 | 1 | 3 | 0 | €895.40 | €958.32 | 7.027% |
| Vertex Pharmaceuticals Inc. | 47 | 2 | 7 | 0 | €407.20 | €409.07 | 0.459% |
| Eli Lilly Corp. | 50 | 0 | 7 | 0 | €750.50 | €786.51 | 4.797% |
| Biogen Inc. | 50 | 1 | 7 | 0 | €197.35 | €293.22 | 48.581% |